Drugs / Influenza A (H1N1) 2009 Monovalent Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00992836 | Oct 2009 → Aug 2010 | HIV infectious disease, swine influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01097941 Comparator | Mar → Sep 2010 | swine influenza | University of Rochester | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza A (H1N1) 2009 monovalent vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00992836 ↗ |
| Known as | Fluvirin | “Two 30-μg doses of 2009 Novartis pH1N1 monovalent vaccine (Fluvirin) were administered 21-28 days apart” PMID 22615311 ↗ May 2012 |
| Modality | Vaccine | “Inactivated Swine-Origin H1N1 Influenza Vaccine” NCT00992836 ↗ |
| Route | Intramuscular | “each dose consisting of two 15-microgram intramuscular injections” NCT00992836 ↗ |